Wasatch Advisors LP Purchases 55,121 Shares of Transcat, Inc. (NASDAQ:TRNS)

Wasatch Advisors LP boosted its position in Transcat, Inc. (NASDAQ:TRNS) by 7.9% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 756,220 shares of the scientific and technical instruments company’s stock after acquiring an additional 55,121 shares during the period. Wasatch Advisors LP owned 0.09% of Transcat worth $84,266,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Arizona State Retirement System boosted its holdings in Transcat by 11.9% in the fourth quarter. Arizona State Retirement System now owns 2,434 shares of the scientific and technical instruments company’s stock worth $266,000 after acquiring an additional 258 shares in the last quarter. Diversified Trust Co raised its stake in shares of Transcat by 4.3% in the fourth quarter. Diversified Trust Co now owns 2,435 shares of the scientific and technical instruments company’s stock worth $266,000 after purchasing an additional 100 shares during the last quarter. Howe & Rusling Inc. purchased a new stake in shares of Transcat in the fourth quarter worth approximately $385,000. Linden Thomas Advisory Services LLC raised its stake in shares of Transcat by 26.9% in the fourth quarter. Linden Thomas Advisory Services LLC now owns 3,841 shares of the scientific and technical instruments company’s stock worth $420,000 after purchasing an additional 814 shares during the last quarter. Finally, Deutsche Bank AG raised its stake in shares of Transcat by 13.2% in the third quarter. Deutsche Bank AG now owns 4,405 shares of the scientific and technical instruments company’s stock worth $432,000 after purchasing an additional 512 shares during the last quarter. Institutional investors own 98.34% of the company’s stock.

Insiders Place Their Bets

In other Transcat news, Director Charles P. Hadeed sold 1,358 shares of the firm’s stock in a transaction on Wednesday, June 12th. The stock was sold at an average price of $130.00, for a total value of $176,540.00. Following the completion of the sale, the director now directly owns 21,320 shares of the company’s stock, valued at $2,771,600. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other news, CEO Lee D. Rudow sold 12,000 shares of the firm’s stock in a transaction on Thursday, May 23rd. The stock was sold at an average price of $135.10, for a total value of $1,621,200.00. Following the completion of the transaction, the chief executive officer now directly owns 91,692 shares of the company’s stock, valued at $12,387,589.20. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Charles P. Hadeed sold 1,358 shares of the firm’s stock in a transaction on Wednesday, June 12th. The stock was sold at an average price of $130.00, for a total value of $176,540.00. Following the completion of the transaction, the director now directly owns 21,320 shares of the company’s stock, valued at $2,771,600. The disclosure for this sale can be found here. Insiders sold 22,215 shares of company stock valued at $2,969,084 over the last ninety days. 4.20% of the stock is currently owned by insiders.

Transcat Stock Performance

NASDAQ:TRNS traded up $4.76 during trading hours on Tuesday, reaching $123.95. The stock had a trading volume of 41,782 shares, compared to its average volume of 40,739. The company has a debt-to-equity ratio of 0.01, a quick ratio of 2.62 and a current ratio of 3.14. The stock has a 50 day simple moving average of $121.70 and a 200 day simple moving average of $111.96. Transcat, Inc. has a 12-month low of $81.26 and a 12-month high of $147.00. The stock has a market cap of $1.13 billion, a P/E ratio of 77.96 and a beta of 0.68.

Transcat (NASDAQ:TRNS) last released its earnings results on Monday, May 20th. The scientific and technical instruments company reported $0.77 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.52 by $0.25. Transcat had a return on equity of 9.50% and a net margin of 5.26%. The business had revenue of $70.91 million during the quarter, compared to the consensus estimate of $68.76 million. On average, research analysts forecast that Transcat, Inc. will post 1.99 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on TRNS. HC Wainwright increased their price target on Transcat from $124.00 to $156.00 and gave the company a “buy” rating in a research report on Wednesday, May 22nd. Oppenheimer increased their price target on Transcat from $125.00 to $160.00 and gave the company an “outperform” rating in a research report on Wednesday, May 22nd. Northland Securities downgraded Transcat from an “outperform” rating to a “market perform” rating in a research report on Wednesday, May 22nd. Finally, Northland Capmk downgraded Transcat from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, May 22nd. Three investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, Transcat presently has a consensus rating of “Hold” and a consensus target price of $142.67.

Transcat Company Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.